Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Up 47.9% in September

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totaling 722,200 shares, an increase of 47.9% from the September 15th total of 488,200 shares. Based on an average daily volume of 421,800 shares, the short-interest ratio is presently 1.7 days. Based on an average daily volume of 421,800 shares, the short-interest ratio is presently 1.7 days.

Bioceres Crop Solutions Stock Down 7.5%

Shares of NASDAQ:BIOX opened at $1.84 on Friday. The company has a 50 day moving average price of $2.05 and a two-hundred day moving average price of $3.49. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. The company has a market capitalization of $115.39 million, a PE ratio of -2.27 and a beta of 0.33. Bioceres Crop Solutions has a 52 week low of $1.20 and a 52 week high of $7.44.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in BIOX. Jones Financial Companies Lllp lifted its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares in the last quarter. PDT Partners LLC acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $81,000. Avanza Fonder AB increased its position in shares of Bioceres Crop Solutions by 62.9% in the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock valued at $117,000 after acquiring an additional 10,099 shares during the last quarter. Finally, Walleye Capital LLC acquired a new position in Bioceres Crop Solutions during the first quarter valued at approximately $199,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Bioceres Crop Solutions in a research note on Friday. Brookline Capital Management downgraded shares of Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 21st. Wall Street Zen lowered shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Canaccord Genuity Group reissued a “hold” rating and set a $2.50 price target (down from $6.50) on shares of Bioceres Crop Solutions in a research note on Wednesday, September 10th. Finally, Oppenheimer lowered shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $4.17.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.